No Data
US Stock MarketDetailed Quotes
SEEL Seelos Therapeutics
Watchlist
1.6600
-0.0300-1.78% Close 12/08 16:00 ET
1.6200-0.0400-2.41%
Post 17:39 ET
1.7169High1.6300Low440.60KVolume
1.7000Open1.6900Pre Close736.95KTurnover6.57%Turnover RatioLossP/E (TTM)12.24MMarket Cap49.800052wk HighLossP/E (Static)7.37MShares1.040052wk Low-0.40P/B11.13MFloat Cap3172500.0000Historical High--Dividend TTM6.71MShs Float1.0400Historical Low--Div YieldTTM5.14%Amplitude1.6720Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Seelos Therapeutics Company
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Revenue Breakdown
Business
Currency:USD
2019/12/31
Stock NameRevenueRatio
Single Segment375K100.00%
News
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersPHAXIAM Therapeutics (NASDAQ:PHXM) shares moved upwards by 22.1% to $5.13 during Tuesday's regular session. The market value of their outstanding shares is at $31.1 million. Travere Therapeutic
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Defense Dept. Funds Ketamine Study For PTSD Treatment A DOD Health Agency-funded adaptive platform trial for alternative treatments for PTSD will test SLS-002 on some 600 active-duty service members
SSNT, MESO and AMPE Among Pre-market Losers
Comments
Next resistance is 2.97.
$Seelos Therapeutics(SEEL.US$ Insiders bought enough shares to make the new support 1.38. Buy at 1.45. Sell at 2.90 for 100% profit. Borrow rate has tripled since Friday.
5
1
$Seelos Therapeutics(SEEL.US$ bullish view …….more like bullshit!!!!! But imma HOLD you to that lol lmfao!!!!
Insiders, including the CFO, may hold a bullish view of Seelos Therapeutics despite its recent losses and limited insider ownership, signaling a possible positive future outlook.
1
4
4
Insider buys
$Seelos Therapeutics(SEEL.US$ Officer Golembiewski Michael Joseph purchased 83,000 shares of Common Stocks on Nov 30, 2023 at an average price of $1.2075 for a total value of $100.22K.
Officer Mehra Raj purchased 75,757 shares of Common Stocks on Dec 1, 2023 at an average price of $1.32 for a total value of $99,999.24.
Officer Mehra Raj purchased 75,757 shares of Common Stocks on Dec 1, 2023 at an average price of $1.32 for a total value of $99,999.24.
1
1
$Seelos Therapeutics (SEEL.US)$ well, write this one off, had hopes for it. I'm sure once it opens again, it will be shorted again to nothing
$Seelos Therapeutics(SEEL.US$ 4.8m float post rs
$Clearmind Medicine(CMND.US$ 400k float post rs
$Yoshiharu Global(YOSH.US$ 500k float post rs
$Clearmind Medicine(CMND.US$ 400k float post rs
$Yoshiharu Global(YOSH.US$ 500k float post rs
3
1
News
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics Selects SLS-002 (Intranasal Racemic Ketamine) For Inclusion In The U.S. Department Of Defense's Adaptive Platform Trial To Evaluate Potential Treatments For Post-traumatic Stress Disorder
2
$Seelos Therapeutics(SEEL.US$
Seelos Therapeutics (SEEL) announced a 1-for-30 reverse stock split, effective November 28, 2023, to regain compliance with Nasdaq's minimum bid price requirement. Following the split, SEEL's common stock will continue trading on the Nasdaq Capital Market under the symbol "SEEL." The reverse split aims to reduce the number of issued and outstanding shares from approximately 167.7 million to around 5.6 million.
This move is often undertaken by companies to meet exc...
Seelos Therapeutics (SEEL) announced a 1-for-30 reverse stock split, effective November 28, 2023, to regain compliance with Nasdaq's minimum bid price requirement. Following the split, SEEL's common stock will continue trading on the Nasdaq Capital Market under the symbol "SEEL." The reverse split aims to reduce the number of issued and outstanding shares from approximately 167.7 million to around 5.6 million.
This move is often undertaken by companies to meet exc...
1
$Seelos Therapeutics(SEEL.US$-29.5M(YOY) where am i going with no buyers in market! buying few for test ride 
3
1
1
$Seelos Therapeutics(SEEL.US$
looks like money
looks like money
$Seelos Therapeutics(SEEL.US$
lets get pump in here
lets get pump in here
+2
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ShawnMoney : Your ass should get paid for this shit……….wait a minute you are lol lmfao!!!!! Good shit Bro!!!!